Skip to main content

Are Oral Dose Manufacturing Projects Becoming More Complicated?

By September 8, 2021October 26th, 2022No Comments

By Kate Hammeke, VP of Market Research, Industry Standard Research (ISR) @ISRreports

For the past six years, Industry Standard Research has asked oral dose outsourcers about the proportions of their projects that are simple, neither simple nor complex, and complex. Considering the formulation challenges and solubility issues that can come with more complex molecules, I anticipated there would be an uptick in the proportions of complex oral dose projects over time. Data from ISR’s research on oral dose manufacturing suggests my hypothesis was wrong. At least for now.